EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Exosomes in Psoriasis: From Pathogenic Mechanisms to Therapeutic Innovations

Qi Xu, Wenting Liu, Siqing Zhang, Lin Zhou

Clinical, Cosmetic and Investigational Dermatology · 2026-06 · Volume 19 · 1-22

DOI: 10.2147/ccid.s606845 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical, Cosmetic and Investigational Dermatology, 2026-06. Verfasst von Qi Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Traditional Chinese Medicine Hospital of Longquanyi, Chengdu, Sichuan Province, 610100, People's Republic of China. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a chronic recurrent inflammatory disease driven by keratinocytes and immune cells. Exosomes, as key mediators of intercellular communication, play multidimensional roles in this disease. In terms of pathogenic mechanisms, exosomes released from psoriatic lesions carry non‑coding RNAs and proteins that program T‑cell polarization, drive M1 macrophage activation, and amplify keratinocyte inflammation, thereby sustaining the IL‑23/Th17 immune axis. Translational breakthroughs have repurposed these same vesicles into diagnostic and therapeutic tools. Circulating exosomal fingerprints offer non‑invasive biomarkers for disease activity and psoriatic arthritis differentiation. Leveraging their biocompatibility and low immunogenicity, exosomes from mesenchymal stem cells, plants, and microbes serve as cell‑free platforms achieving immune regulation, antioxidant effects, and microecological repair. Engineering strategies-including cargo loading, membrane surface modification and intelligent microneedle delivery systems-further enhance targeting and efficacy. Despite these advances, clinical translation faces fundamental challenges: lack of production standardization, undefined core active components and insufficient high‑level clinical evidence. Future efforts should prioritize international standards, rational design, and rigorous trials to accelerate exosome‑based precision medicine for psoriasis.

Schlagwörter

Stichwörter der Autor:innen

biomarkerscell-free therapyexosomesimmunomodulationpsoriasis

Autor:innen und Institutionen

  • Department of Dermatology, The Traditional Chinese Medicine Hospital of Longquanyi, Chengdu, Sichuan Province, 610100, People's Republic of China.
  • Department of Intensive Care Unit, Foshan Hospital of Traditional Chinese Medicine, Foshan, Guangdong Province, 528099, People's Republic of China.
  • Shishan Community Health Service Center, Foshan City, Guangdong Province, 528234, People's Republic of China.

Zitieren

APA

Xu, Q., Liu, W., Zhang, S., & Zhou, L. (2026). Exosomes in Psoriasis: From Pathogenic Mechanisms to Therapeutic Innovations. Clinical, Cosmetic and Investigational Dermatology, Volume 19, 1-22. https://doi.org/10.2147/ccid.s606845

Vancouver

Xu Q, Liu W, Zhang S, Zhou L. Exosomes in Psoriasis: From Pathogenic Mechanisms to Therapeutic Innovations. Clinical, Cosmetic and Investigational Dermatology. 2026;Volume 19:1-22. doi:10.2147/ccid.s606845

BibTeX
@article{Xu2026,
  author = {Xu, Qi and Liu, Wenting and Zhang, Siqing and Zhou, Lin},
  title = {Exosomes in Psoriasis: From Pathogenic Mechanisms to Therapeutic Innovations},
  journal = {Clinical, Cosmetic and Investigational Dermatology},
  year = {2026},
  volume = {Volume 19},
  pages = {1--22},
  doi = {10.2147/ccid.s606845}
}
Kostenlos starten →